Thermo Fisher Scientific Expands Steriles Manufacturing and Research Capabilities in Asia-Pacific Region
The cost of poor quality simply cannot be absorbed in today’s biopharmaceutical manufacturing environment. Reproducing large molecules reliably at commercial scale is a complex, expensive, and high-risk endeavor. Doing so in the face of a stretched supply chain, global economic uncertainty, and competitive pressure to improve speed and productivity leaves no room for product, process, or planning deficiencies.
The growing reliance on outsourcing development and manufacturing activities positions biopharma companies to more quickly implement and scale product development, but only if all stakeholders maintain a continuous focus on quality across every stage of the manufacturing lifecycle. This level of focus can be achieved through robust and resilient digital operations that support transparent communication, strategic collaboration, and cross-team accountability.
In this webinar, we will discuss customer-centric digital transformations that are improving overall process and product quality and performance and transforming CDMO relationships by: